Inicio>>Infectious Disease>> Viral Diseases>> Hepatitis>>6-Hydroxypyridin-3-ylboronic Acid

6-Hydroxypyridin-3-ylboronic Acid

Catalog No.GC46724

A heterocyclic building block

Products are for research use only. Not for human use. We do not sell to patients.

6-Hydroxypyridin-3-ylboronic Acid Chemical Structure

Cas No.: 903899-13-8

Tamaño Precio Disponibilidad Cantidad
100 mg
101,00 $
Disponible
250 mg
240,00 $
Disponible
500 mg
455,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

6-Hydroxypyridin-3-ylboronic acid is a heterocyclic building block.1,2 It has been used in the synthesis of non-nucleoside inhibitors of hepatitis C virus (HCV) RNA-dependent RNA polymerase nonstructural protein 5B (NS5B).1 6-Hydroxypyridin-3-ylboronic acid has also been used in the synthesis of mammalian target of rapamycin (mTOR) inhibitors.2

1.Hendricks, R.T., Spencer, S.R., Blake, J.F., et al.3-Hydroxyisoquinolines as inhibitors of HCV NS5b RNA-dependent RNA polymeraseBioorg. Med. Chem. Lett.19(2)410-414(2009) 2.Verheijen, J.C., Richard, D.J., Curran, K., et al.Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and sselective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): Optimization of the 6-aryl substituentJ. Med. Chem.52(24)8010-8024(2009)

Reseñas

Review for 6-Hydroxypyridin-3-ylboronic Acid

Average Rating: 5 ★★★★★ (Based on Reviews and 11 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 6-Hydroxypyridin-3-ylboronic Acid

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.